Utang jangka cendhak marang modal: AngioDynamics Inc (ANGO)

Logo korporat perusahaan AngioDynamics, Inc. (ANGO)

AngioDynamics, Inc. (ANGO) generates revenue through the sale of vascular therapy systems and oncology equipment. FDA certifications and patent protection ensure a high barrier to entry. The asset value of 0.02 shown on this chart reflects the financial dynamics. A team of top-tier engineers drives innovation here, receiving competitive benefits and long-term job security in return.

ANGO - Koefisien utang jangka cendhak marang modal AngioDynamics Inc ing rentang 04.07.2022 - 29.10.2026
Produk merek AngioDynamics

An optimal capital structure separates sustainable development from risky speculation. The strategic focus of AngioDynamics, Inc. (ANGO) on high-tech proprietary devices in vascular surgery strengthens its financial foundation. The dynamics of the short-term debt-to-equity ratio reflect the proportion of current loans to equity, revealing the dependency on short-term borrowings. Low values of this ratio confirm the business's protection against credit shocks and its high solvency.

Pesaing langsung

Utang jangka cendhak marang modal ISRG|DHR - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang modal BDX (Becton Dickinson & Co)|STE: Rasio utang jangka cendhak marang modal|West Pharmaceutical Services, Inc. - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal Baxter International Inc. BAX|MASI: Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas Stevanato Group Corp|TFX (Teleflex Incorporated) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal merit.com|Utang jangka cendhak marang ekuitas Envista (NVST)|Utang jangka cendhak marang ekuitas ICUI (ICU Medical Inc)|Dentsply - Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal LMAT|AtriCure, Inc. - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal staar.com STAA|Niagen (NAGE) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang modal ZIMV|Utang jangka cendhak marang ekuitas Cerus Corp|Teknova Inc (TKNO) - Koefisien utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas MGRM (Monogram Technologies)|Rasio silihan jangka cendhak marang modal STSS|Utang jangka cendhak marang ekuitas InfuSystem Holdings, Inc. INFU|Rasio tanggungan utang jangka cendhak marang modal UTMD|KRMD: Rasio utang jangka cendhak marang ekuitas|NYXH - Utang jangka cendhak marang modal|Microbot Medical Inc. (MBOT) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas pro-dex.com|ZTEK (Zentek) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Elutia Inc ELUT|Utang jangka cendhak marang ekuitas Milestone Scientific Corp (MLSS)|NEXGEL Inc - Rasio utang jangka cendhak marang modal|Retractable Technologies, Inc. - Rasio utang jangka cendhak marang ekuitas|Rasio silihan jangka cendhak marang modal HBIO (Harvard Bioscience Inc.)|FEMY - Utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal MeihuaMed MHUA|POAI: Utang jangka cendhak marang modal|Callan JMB (CJMB) - Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Atrion Corporation|Rasio utang jangka cendhak marang modal NURO (neurometrix.com)